Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Combined burden and functional impact tests for cancer driver discovery using DriverPower

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genomic footprints of activated telomere maintenance mechanisms in cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pathway and network analysis of more than 2500 whole cancer genomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Precapillary sphincters maintain perfusion in the cerebral cortex

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  • EMBRACE Collaborators
View graph of relations

Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.

Original languageEnglish
JournalNature Communications
Volume10
Issue number1
Pages (from-to)1741
ISSN2041-1723
DOIs
Publication statusPublished - 15 Apr 2019

    Research areas

  • Breast Neoplasms/genetics, Female, Gene Expression Profiling, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Quantitative Trait Loci

ID: 59010826